| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.1M | -22.3% | — |
| R&D Expense | $19.5M | -55.1% | -60.3% |
| SG&A Expense | $10.1M | -30.1% | +3.1% |
| Operating Income | -$15.4M | +61.4% | +73.8% |
| Pre-tax Income | -$8.7M | +73.6% | +83.6% |
| Income Tax | -$1.4M | +35.9% | — |
| Net Income | -$7.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $693.5M | +0.5% | +30.7% |
| Accounts Receivable | $3.5M | -77.9% | +800.0% |
| Current Assets | $719.3M | -1.8% | +30.3% |
| Total Assets | $742.8M | -1.9% | +28.2% |
| Current Liabilities | $24.1M | -30.6% | -16.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $134.8M | — | — |
| Capital Expenditures | $1.4M | — | — |
| Investing Cash Flow | -$1.4M | — | — |
| Financing Cash Flow | $161K | — | — |
| Free Cash Flow | $133.4M | — | — |
| +86.3% |
| EPS (Basic) | -$0.18 | +76.3% | +87.2% |
| EPS (Diluted) | -$0.18 | +76.3% | +87.2% |
| $39.2M |
| -22.3% |
| -15.6% |
| Stockholders' Equity | $703.6M | -0.4% | +32.0% |